Robert Oexman, DC - NeuroCon 2020
Channel: ParkerSeminars
Date: 19/06/2020

Robert D. Oexman, is currently CEO and Founder of Somly, a telemedicine company treating insomnia using Cognitive Behavioral Therapy. He previously developed and managed a sleep research facility that employed sleep and engineering technicians to study the impact that the environment and pain have on human sleep. Managed research projects at Stanford, Harvard, Toronto, and Duke University. Developed and patented unique testing equipment for monitoring sleep. Developed and managed a medical and research division for a multi-national fortune 500 company. 

His topic at NeuroCon 2020 is TREATING PATIENTS WITH PRIMARY AND COMORBID INSOMNIA USING CBT-I Cognitive Behavioral Therapy for Insomnia (CBT-I) is a non-pharmaceutical approach for the treatment for insomnia. It differs somewhat from CBT used to treat other medical and psychiatric conditions.